BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28392019)

  • 1. The importance of bisphenol A, an uraemic toxin from exogenous sources, in haemodialysis patients.
    Mas S; Egido J; González-Parra E;
    Nefrologia; 2017; 37(3):229-234. PubMed ID: 28392019
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphenol A in Hemodialysis Patient: An Open Question.
    Neri M
    Blood Purif; 2016; 42(1):75-6. PubMed ID: 27189594
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies to Protect Dialysis Patients against Bisphenol A.
    Quiroga B
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemoperfusion results in uremia.
    Gelfand MC; Winchester JF
    Clin Nephrol; 1979 Feb; 11(2):107-10. PubMed ID: 378488
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: serum bisphenol-a concentration and sex hormone levels in men.
    Niederberger C
    J Urol; 2014 Feb; 191(2):435. PubMed ID: 24411895
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of haemodialysis on immune response.
    Gombos EA; Jefferson DM; Bhat JG
    Proc Eur Dial Transplant Assoc; 1975; 11():367-73. PubMed ID: 1197260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of beta-endorphin in uraemic patients during haemodialysis.
    Caruso U; Lezoche E; Mariani P; Elli M; Tisone G; Cravotto E; Casciani CU
    Int J Clin Pharmacol Res; 1988; 8(1):17-20. PubMed ID: 2966773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of haemostasis in fifteen uraemic patients subjected to chronic haemodialysis (author's transl)].
    Barrantes Boulanger A; Soto Quirós M; Salas González R
    Sangre (Barc); 1980; 25(3):289-99. PubMed ID: 7414445
    [No Abstract]   [Full Text] [Related]  

  • 9. Middle-sized ninhydrin-positive molecules in uraemic patients treated by repeated haemodialysis. I. Preliminary characteristics.
    Hanicki Z; Sarnecka-Keller M; Klein A; Slizowska K
    Clin Chim Acta; 1974 Jul; 54(1):47-54. PubMed ID: 4847123
    [No Abstract]   [Full Text] [Related]  

  • 10. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
    Krieter DH; Hackl A; Rodriguez A; Chenine L; Moragues HL; Lemke HD; Wanner C; Canaud B
    Nephrol Dial Transplant; 2010 Jan; 25(1):212-8. PubMed ID: 19755476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of insulin binding to erythrocyte insulin receptors in uraemia by haemodialysis.
    Milutinović S; Breyer D; Janković M; Stefović A; Molnar V; Mrzljak V; Rocić B
    Proc Eur Dial Transplant Assoc; 1983; 19():763-8. PubMed ID: 6348765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipids in uraemic patients on regular haemodialysis.
    Pierides AM; Weightman D; Goldfinch M; Tsoukantas A; Kerr DN
    Proc Eur Dial Transplant Assoc; 1976; 12():397-402. PubMed ID: 935128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily diet containing canned products significantly increases serum concentrations of endocrine disruptor bisphenol A in young women.
    Szybiak A; Rutkowska A; Wilczewska K; Wasik A; Namieśnik J; Rachoń D
    Pol Arch Intern Med; 2017 Apr; 127(4):278-280. PubMed ID: 28436414
    [No Abstract]   [Full Text] [Related]  

  • 14. Bisphenol A in chronic kidney disease.
    Krieter DH; Canaud B; Lemke HD; Rodriguez A; Morgenroth A; von Appen K; Dragoun GP; Wanner C
    Artif Organs; 2013 Mar; 37(3):283-90. PubMed ID: 23145999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volatile phenols in serum of uraemic patients.
    Wengle B; Hellström K
    Clin Sci; 1972 Oct; 43(4):493-8. PubMed ID: 4653588
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of dialysis membrane composition on plasma bisphenol A levels during online hemodiafiltration.
    Mas S; Bosch-Panadero E; Abaigar P; Camarero V; Mahillo I; Civantos E; Sanchez-Ospina D; Ruiz-Priego A; Egido J; Ortiz A; González-Parra E
    PLoS One; 2018; 13(3):e0193288. PubMed ID: 29529055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The phenolemia in patients treated with plasmadialysis. (Preliminary note)].
    Lollis B; Legnani F
    Friuli Med; 1967; 22(3):555-60. PubMed ID: 5615191
    [No Abstract]   [Full Text] [Related]  

  • 18. Higher Serum Bisphenol A Levels in Diabetic Hemodialysis Patients.
    Turgut F; Sungur S; Okur R; Yaprak M; Ozsan M; Ustun I; Gokce C
    Blood Purif; 2016; 42(1):77-82. PubMed ID: 27193155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
    Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
    Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum gastrin in uraemic patients on intermittent haemodialysis following a test meal (author's transl)].
    Pointner H; Flegel U; Schmidt P; Zazgornik J; Kopsa H; Waldhäusl W
    Wien Klin Wochenschr; 1974 Nov; 86(22):699-702. PubMed ID: 4460394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.